Halozyme Therapeutics, Inc. · NASDAQ:HALO

BlackRock, Inc. reported a 13.10% stake in Halozyme Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 28, 2025

BlackRock, Inc. reported a 13.10% stake in Halozyme Therapeutics, Inc., 16,144,164 shares, as a passive investor on Mar 31, 2025. Filed Apr 28, 2025 (Schedule 13G/A).

Stake
13.10%
Shares
16,144,164
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.13.10%16,144,164

Source

View original at SEC

Related